Nine European Hospitals Receive Awards in Rome

HIMSS EuropeThe analytics unit of HIMSS Europe awarded nine European hospitals with a Stage 6 Award during an awards ceremony at the annual CIO Summit, taking place in Rome from 6 - 7 October.

The awarded hospitals are: Galway Clinic with 146 beds, Azienda Ospedaliera of Vimercate with 527 beds, Zaans Medisch Centrum with 290 beds, Izmir Tire Devlet Hastanesi with 232 beds, Rize Devlet Hastanesi, Rize with 293 beds, Mersin Erdemli Devlet Hastanesi with 159 beds, Bursa Dörtçelik Hastanesi with 350 beds, Croydon University Hospital with 518 beds and Polyclinique de la Clarence with 205 beds.

It is the first time that hospitals in the UK and Ireland receive an EMRAM Stage 6 Award. There are now three Stage 6 hospitals in Italy, nine in France, eleven in the Netherlands and five in Turkey. In total there are fifty-two (52) hospitals in Europe recognized with the Stage 6, and two hospitals with the Stage 7, one in Germany and one in Spain.

The European EMR Adoption Model (EMRAM) has been adapted to meet the unique needs of European Healthcare Institutions as a methodology for evaluating the progress and impact of electronic medical record systems in hospitals. Tracking their progress in completing eight stages (0‐7), hospitals can review the implementation and utilization of information technology applications with the intent of reaching Stage 7, which represents a superior electronic patient record environment.

Stage 6 & 7 hospitals provide best practices that other healthcare organizations can study as they strive to use EMR applications to improve patient safety, clinical outcomes and patient care delivery efficiency.

Rainer Herzog, Managing Director, HIMSS Europe "At this year's CIO Summit we are happy to award not only the largest number of Stage 6 hospitals to date, but also hospitals from a range of countries, including two "newcomers" - Ireland and UK. Especially noteworthy is that four of eight award recipients are from Turkey, which reflects the great commitment of the Turkish health authorities to embracing new technologies for the betterment of healthcare."

About HIMSS Analytics
The analytics unit of HIMSS Europe provides health care organisations, governments and industry with extensive data resources and services about the adoption and use of healthcare information technology in Europe. Offerings include comparative Hospital IT adoption benchmarking, a European‐formulated EMR Adoption Model (EMRAM) scale, and other resources to help hospital directors, IT executives and clinicians compare and measure their progress and how they compare to others. Country level and application specific reports also provide insights into major IT adoption trends and applications.

About HIMSS
HIMSS is a global, cause-based, not-for-profit organization focused on better health through information technology (IT). HIMSS leads efforts to optimize health engagements and care outcomes using information technology.

HIMSS is a part of HIMSS WorldWide, a cause-based, global enterprise producing health IT thought leadership, education, events, market research and media services around the world. Founded in 1961, HIMSS WorldWide encompasses more than 52,000 individuals, of which more than two-thirds work in healthcare provider, governmental and not-for-profit organizations across the globe, plus over 600 corporations and 250 not-for-profit partner organizations, that share this cause. HIMSS WorldWide, headquartered in Chicago, serves the global health IT community with additional offices in the United States, Europe, and Asia.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...